What Is Lipid Emulsion Therapy?
Intravenous lipid emulsion (ILE) therapy, commonly known by the brand name Intralipid, is a fat-based solution originally developed for parenteral nutrition. In emergency medicine, it is used as a rescue therapy for life-threatening toxicity from lipophilic (fat-soluble) drugs, particularly local anesthetics. Its use has expanded to include other lipophilic drug overdoses when conventional treatments fail.
Mechanism of Action
The exact mechanism is not fully understood, but the leading theories include:
- Lipid sink: The lipid emulsion creates a separate lipid compartment in the blood that absorbs lipophilic drug molecules, pulling them away from cardiac and neural tissue and reducing their toxic effects
- Direct cardiac effects: Lipid emulsion may provide fatty acids as an energy substrate for the myocardium, improving cardiac contractility in the setting of drug-induced cardiac depression
- Enhanced drug redistribution: The lipid phase may accelerate the redistribution of toxic drugs from target organs to storage sites
Indications
ILE is indicated as a rescue therapy when standard treatments have failed for toxicity from:
- Local anesthetics: Bupivacaine toxicity is the best-studied indication. Last resort after seizure control and hemodynamic support fail.
- Tricyclic antidepressants: When sodium bicarbonate and vasopressors are insufficient
- Calcium channel blockers: Refractory to calcium, glucagon, and vasopressors
- Beta-blockers: Refractory to standard antidotal therapy
- Other lipophilic drugs: Case reports exist for verapamil, bupropion, and other lipid-soluble agents
Dosing Protocol
The standard protocol for 20% lipid emulsion in adults:
- Bolus: 1.5 mL/kg IV over 1 minute (approximately 100 mL for a 70 kg patient)
- Infusion: 0.25 mL/kg/min for 30 to 60 minutes
- Repeat bolus: May repeat the bolus once or twice if hemodynamic instability persists
- Maximum dose: 12 mL/kg total
Prehospital Considerations
Not all EMS agencies carry lipid emulsion, and its prehospital use is relatively uncommon. If your agency stocks it, know where it is stored, how to prepare it, and the indications for administration. The decision to administer ILE in the field should be made in consultation with medical control whenever possible. Document the toxin involved, all prior treatments administered, the ILE dose and infusion rate, and the patient's hemodynamic response.